BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spoerri PE, Caballero S, Wilson SH, Shaw LC, Grant MB. Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis. Invest Ophthalmol Vis Sci. 2003;44:365-369. [PMID: 12506097 DOI: 10.1167/iovs.02-0309] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Romaniuk D, Kimsa MW, Strzalka-Mrozik B, Kimsa MC, Kabiesz A, Romaniuk W, Mazurek U. Gene expression of IGF1, IGF1R, and IGFBP3 in epiretinal membranes of patients with proliferative diabetic retinopathy: preliminary study. Mediators Inflamm 2013;2013:986217. [PMID: 24379526 DOI: 10.1155/2013/986217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
2 Kielczewski JL, Hu P, Shaw LC, Li Calzi S, Mames RN, Gardiner TA, McFarland E, Chan-Ling T, Grant MB. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 2011;178:1517-28. [PMID: 21435441 DOI: 10.1016/j.ajpath.2010.12.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
3 Kokona D, Mastrodimou N, Pediaditakis I, Charalampopoulos I, Schmid HA, Thermos K. Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies. Exp Eye Res 2012;103:90-8. [PMID: 22960304 DOI: 10.1016/j.exer.2012.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
4 Siegel G, Schäfer R, Dazzi F. The Immunosuppressive Properties of Mesenchymal Stem Cells. Transplantation 2009;87:S45-9. [DOI: 10.1097/tp.0b013e3181a285b0] [Cited by in Crossref: 115] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
5 Wu JH, Wang YH, Wang W, Shen W, Sang YZ, Liu L, Chen CM. MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. Int J Biochem Cell Biol 2016;73:41-52. [PMID: 26851511 DOI: 10.1016/j.biocel.2016.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
6 Wang CH, Tang CW, Liu CL, Tang LP. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9(9): 1904-1908 [PMID: 12970873 DOI: 10.3748/wjg.v9.i9.1904] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
7 Dong L, Nian H, Shao Y, Zhang Y, Li Q, Yi Y, Tian F, Li W, Zhang H, Zhang X, Wang F, Li X. PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy. Cell Tissue Res 2015;360:233-43. [PMID: 25638408 DOI: 10.1007/s00441-014-2104-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang X, Zhao L, Hambly B, Bao S, Wang K. Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets.Cell Biosci. 2017;7:42. [PMID: 28815013 DOI: 10.1186/s13578-017-0167-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xi G, Wai C, Clemmons D. Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic Retinopathy. J Diabetes Res 2019;2019:6456032. [PMID: 31049357 DOI: 10.1155/2019/6456032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Müller I. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood. 2007;110:2197-2200. [PMID: 17522338 DOI: 10.1182/blood-2007-04-083162] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
11 Maffei P, Dassie F, Wennberg A, Parolin M, Vettor R. The Endothelium in Acromegaly. Front Endocrinol (Lausanne) 2019;10:437. [PMID: 31396153 DOI: 10.3389/fendo.2019.00437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
12 Pescosolido N, Campagna O, Barbato A. Diabetic retinopathy and pregnancy. Int Ophthalmol. 2014;34:989-997. [PMID: 24482250 DOI: 10.1007/s10792-014-9906-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
13 Rosenzweig SA. What's new in the IGF-binding proteins. Growth Horm IGF Res. 2004;14:329-336. [PMID: 15336228 DOI: 10.1016/j.ghir.2004.02.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
14 Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, Baxter LC, Shaw LC, Caballero S, Sengupta N, Li Calzi S, Sullivan SM, Grant MB. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A 2007;104:10595-600. [PMID: 17567755 DOI: 10.1073/pnas.0702072104] [Cited by in Crossref: 87] [Cited by in F6Publishing: 96] [Article Influence: 6.2] [Reference Citation Analysis]
15 Keku TO, Sandler RS, Simmons JG, Galanko J, Woosley JT, Proffitt M, Omofoye O, McDoom M, Lund PK. Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas. BMC Cancer 2008;8:143. [PMID: 18498652 DOI: 10.1186/1471-2407-8-143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
16 Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy. J Diabetes Complications 2005;19:297-304. [PMID: 16112506 DOI: 10.1016/j.jdiacomp.2005.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Shaw LC, Grant MB. Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology. Rev Endocr Metab Disord 2004;5:199-207. [PMID: 15211091 DOI: 10.1023/B:REMD.0000032408.18015.b1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
18 Zhang Q, Jiang Y, Miller MJ, Peng B, Liu L, Soderland C, Tang J, Kern TS, Pintar J, Steinle JJ. IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci 2013;54:5376-84. [PMID: 23868984 DOI: 10.1167/iovs.13-12497] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
19 Giannini S, Cresci B, Manuelli C, Pala L, Rotella CM. Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. J Endocrinol Invest 2006;29:754-63. [DOI: 10.1007/bf03344189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
20 Zhang Q, Steinle JJ. DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose. Invest Ophthalmol Vis Sci 2013;54:3052-7. [PMID: 23557743 DOI: 10.1167/iovs.12-11533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
21 Vasilaki A, Thermos K. Somatostatin analogues as therapeutics in retinal disease. Pharmacology & Therapeutics 2009;122:324-33. [DOI: 10.1016/j.pharmthera.2009.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
22 Nguyen DV, Li Calzi S, Shaw LC, Kielczewski JL, Korah HE, Grant MB. An ocular view of the IGF-IGFBP system. Growth Horm IGF Res 2013;23:45-52. [PMID: 23578754 DOI: 10.1016/j.ghir.2013.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]